[1]凡庆东,姜军,杨新华,等.新辅助化疗对乳腺癌Survivin、p53表达影响及意义[J].第三军医大学学报,2007,29(11):1096-1098.
 FAN Qing-dong,JIANG Jun,YANG Xin-hua,et al.Effect of neoadjuvant chemotherapy on Survivin, p53 expression in breast cancer[J].J Third Mil Med Univ,2007,29(11):1096-1098.
点击复制

新辅助化疗对乳腺癌Survivin、p53表达影响及意义
(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
29卷
期数:
2007年第11期
页码:
1096-1098
栏目:
论著
出版日期:
2007-06-15

文章信息/Info

Title:
Effect of neoadjuvant chemotherapy on Survivin, p53 expression in breast cancer
作者:
凡庆东姜军杨新华范林军钟玲
第三军医大学西南医院乳腺疾病中心
Author(s):
FAN Qing-dong JIANG Jun YANG Xin-hua FAN Lin-jun ZHONG Ling
Breast Disease Center, Southwest Hospital, Third Military Medical University, Chongqing 400038, China
关键词:
乳腺癌 新辅助化疗 Survivin p53
Keywords:
breast cancer neoadjuvant chemotherapy Survivin p53
分类号:
R730.23; R730.53; R737.9
文献标志码:
A
摘要:
目的    探讨乳腺癌新辅助化疗前后Survivin、 p53蛋白表达变化,分析表达变化与临床疗效的关系。    方法    51例可手术女性乳腺癌患者采用TE方案新辅助化疗,免疫组化S-P法检测新辅助化疗前后Survivin、p53蛋白表达情况。    结果    ① 化疗后Survivin表达明显下降,p53表达未见显著性变化。②化疗后Survivin表达降低,化疗有效率高,Survivin的表达升高,化疗有效率低,两者有显著性差异(P<0.05),p53表达变化之间化疗有效率无显著性差异(P>0.05)。    结论     Survivin在新辅助化疗后表达显著降低, Survivin可能是TE方案新辅助化疗的一个靶点。
Abstract:
Objective    To study the expression changes of Survivin, p53 in breast cancer after neoadjuvant chemotherapy and analyze the relationship between expression changes and efficiency of neoadjuvant chemotherapy.      Methods    The expressions of Survivin, p53 were examined by immunohistochemical assay in breast tissue samples from 51 operable breast cancer patients before and after neoadjuvant chemotherapy of TE (Taxinol and Epirubicin) regimen.      Results    After neoadjuvant chemotherapy, the expression of Survivin decreased significantly (P<0.05), but p53 showed no significant changes. Altered expression of Survivin was correlated with efficiency of neoadjuvant chemotherapy (P<0.05).     Conclusion    After neoadjuvant chemotherapy of TE regimen, the expression of Survivin decreased. The gene Survivin may be a target gene in this regimen.

参考文献/References:

凡庆东, 姜军, 杨新华, 等. 新辅助化疗对乳腺癌Survivin、p53表达影响及意义[J]. 第三军医大学学报, 2007, 29(11):1096-1098.

相似文献/References:

[1]朱宁生,张婧,曾晓华,等.BMP-4基因影响乳腺癌细胞增殖、凋亡和迁移能力涉及NF-κB途径[J].第三军医大学学报,2012,34(18):1910.
[2]陈显春,杨英,宋爽,等.乳腺癌患者发生化疗性静脉炎的原因分析及防治对策[J].第三军医大学学报,2007,29(21):2055.
[3]张毅,周艳,郭美琴,等.全乳大切片观察新辅助化疗后乳腺癌浸润性生长特征变化[J].第三军医大学学报,2007,29(21):2083.
 ZHANG Yi,ZHOU Yan,GUO Mei-qin,et al.Infiltrating characteristics of breast cancer after neoadjuvant chemotherapy: whole breast serial subsection observation[J].J Third Mil Med Univ,2007,29(11):2083.
[4]陈显春,杨英,宋爽,等.乳腺癌病友联谊会对提高乳腺癌患者生活质量的作用[J].第三军医大学学报,2007,29(20):1967.
[5]邓莉,张轩珍,王卫东,等.重组人内皮抑素联合紫杉醇+顺铂化疗方案治疗人乳腺癌祼鼠移植瘤的研究[J].第三军医大学学报,2008,30(09):783.
 DENG Li,ZHANG Xuan-zhen,WANG Wei-dong,et al.Recombinant human endostatin combined with paclitaxel-cisplatin chemotherapy in treatment of human breast cancer xenograft in nude mice[J].J Third Mil Med Univ,2008,30(11):783.
[6]黄红梅,陈显春.男性乳腺癌患者的心理分析及对策[J].第三军医大学学报,2007,29(23):2222.
[7]杨新华,姜军,范林军,等.乳腺癌腔镜内乳淋巴结清扫的初步研究[J].第三军医大学学报,2007,29(17):1719.
 YANG Xin-hua,JIANG Jun,FAN Lin-jun,et al.Thoracoscopic internal mammary nodes dissection for breast cancer[J].J Third Mil Med Univ,2007,29(11):1719.
[8]廖翠薇,邹利光,戴书华,等.动态增强磁共振成像对乳腺癌的诊断[J].第三军医大学学报,2008,30(16):1516.
 LIAO Cui-wei,ZOU Li-guang,DAI Shu-hua,et al.Diagnosis of breast cancer with dynamic contrast-enhanced magnetic resonance imaging[J].J Third Mil Med Univ,2008,30(11):1516.
[9]张涛,汤为学,蔡辉,等.不同转移潜能乳腺癌细胞亚系的建立与生物学特性的分析[J].第三军医大学学报,2008,30(18):1726.
 ZHANG Tao,TANG Wei-xue,CAI Hui,et al.Establishment of breast cancer cell sublines with different potential of metastasis and their biological characteristics[J].J Third Mil Med Univ,2008,30(11):1726.
[10]李霞,邓华瑜.格尔德霉素对乳腺癌细胞HSP、突变型p53和CDK4表达的影响[J].第三军医大学学报,2007,29(13):1320.
 LI Xia,DENG Hua-yu.Effects of geldanamycin on expression of HSP, mutant p53 and CDK4 in human breast cancer cells[J].J Third Mil Med Univ,2007,29(11):1320.

更新日期/Last Update: 2008-10-23